795 related articles for article (PubMed ID: 26538067)
1. Prevalence and genotypic characterization of Human Parvovirus B19 in children with measles- and rubella-like illness in Iran.
Rezaei F; Sarshari B; Ghavami N; Meysami P; Shadab A; Salimi H; Mokhtari-Azad T
J Med Virol; 2016 Jun; 88(6):947-53. PubMed ID: 26538067
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and genotypic characterization of human parvovirus B19 in children with hemato-oncological disorders in North India.
Jain P; Jain A; Prakash S; Khan DN; Singh DD; Kumar A; Moulik NR; Chandra T
J Med Virol; 2015 Feb; 87(2):303-9. PubMed ID: 25087946
[TBL] [Abstract][Full Text] [Related]
3. Detection of human parvovirus B19 in serum samples from children under 5 years of age with rash-fever illnesses in the Democratic Republic of the Congo.
Wawina TB; Tshiani OM; Ahuka SM; Pukuta ES; Aloni MN; Kasanga CJ; Muyembe JT
Int J Infect Dis; 2017 Dec; 65():4-7. PubMed ID: 28951104
[TBL] [Abstract][Full Text] [Related]
4. Identification of human parvovirus B19 among measles and rubella suspected patients from Cuba.
de Los Ángeles Ribas M; Tejero Y; Cordero Y; Pérez D; Sausy A; Muller CP; Hübschen JM
J Med Virol; 2019 Jul; 91(7):1351-1354. PubMed ID: 30817853
[TBL] [Abstract][Full Text] [Related]
5. Genotype 3b of human parvovirus B19 detected from hospitalized children with solid malignancies in a North Indian tertiary care hospital.
Jain A; Jain P; Prakash S; Kumar A; Khan DN; Seth A; Gupta S; Kant R
J Med Virol; 2016 Nov; 88(11):1922-9. PubMed ID: 27116539
[TBL] [Abstract][Full Text] [Related]
6. Insights into epidemiology of human parvovirus B19 and detection of an unusual genotype 2 variant, Bulgaria, 2004 to 2013.
Ivanova SK; Mihneva ZG; Toshev AK; Kovaleva VP; Andonova LG; Muller CP; Hübschen JM
Euro Surveill; 2016; 21(4):. PubMed ID: 26847955
[TBL] [Abstract][Full Text] [Related]
7. Contribution of parvovirus B19 in suspected cases of measles/rubella in Osaka, Japan, between 2011 and 2021.
Kaida Y; Kanbayashi D; Kurata T; Mori H
J Med Virol; 2023 Mar; 95(3):e28593. PubMed ID: 36811343
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors.
Oh DJ; Lee YL; Kang JW; Kwon SY; Cho NS
Korean J Lab Med; 2010 Feb; 30(1):58-64. PubMed ID: 20197724
[TBL] [Abstract][Full Text] [Related]
9. Parvovirus B19 seroprevalence, viral load, and genotype characterization in volunteer blood donors from southern Brazil.
Slavov SN; Rodrigues ES; Sauvage V; Caro V; Diefenbach CF; Zimmermann AM; Covas DT; Laperche S; Kashima S
J Med Virol; 2019 Jul; 91(7):1224-1231. PubMed ID: 30851123
[TBL] [Abstract][Full Text] [Related]
10. [Monitoring of implementation of international programs of poliomyelitis eradication and measles and rubella elimination in the Republic of Belarus].
Zh Mikrobiol Epidemiol Immunobiol; 2012; (1):21-30. PubMed ID: 22442967
[TBL] [Abstract][Full Text] [Related]
11. Oral fluid: Non-invasive alternative for parvovirus B19 diagnosis?
Bodewes R; Kerkhof J; Cremer J; Gijselaar DB; Voordouw BCG; Veldhuijzen IK; Schipper M; van Binnendijk R
J Clin Virol; 2019 Aug; 117():5-10. PubMed ID: 31128380
[TBL] [Abstract][Full Text] [Related]
12. Molecular and phylogenetic analyses of human Parvovirus B19 isolated from Brazilian patients with sickle cell disease and β-thalassemia major and healthy blood donors.
Slavov SN; Haddad SK; Silva-Pinto AC; Amarilla AA; Alfonso HL; Aquino VH; Covas DT
J Med Virol; 2012 Oct; 84(10):1652-65. PubMed ID: 22930515
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and Phylogenetic Analysis of Parvovirus (B19V) among Blood Donors with Different Nationalities Residing in Qatar.
Abdelrahman D; Al-Sadeq DW; Smatti MK; Taleb SA; AbuOdeh RO; Al-Absi ES; Al-Thani AA; Coyle PV; Al-Dewik N; Qahtani AAA; Yassine HM; Nasrallah GK
Viruses; 2021 Mar; 13(4):. PubMed ID: 33805034
[TBL] [Abstract][Full Text] [Related]
14. Epidemiologic study of human parvovirus B19 infection in East China.
Zhang L; Cai C; Pan F; Hong L; Luo X; Hu S; Xu J; Chen Z
J Med Virol; 2016 Jul; 88(7):1113-9. PubMed ID: 26705119
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence, molecular epidemiology and quantitation of parvovirus B19 DNA levels in Iranian blood donors.
Zadsar M; Aghakhani A; Banifazl M; Kazemimanesh M; Tabatabaei Yazdi SM; Mamishi S; Bavand A; Sadat Larijani M; Ramezani A
J Med Virol; 2018 Aug; 90(8):1318-1322. PubMed ID: 29663448
[TBL] [Abstract][Full Text] [Related]
16. Acute human parvovirus B-19 infection in hospitalized children: A serologic and molecular survey.
Miron D; Luder A; Horovitz Y; Izkovitz A; Shizgreen I; Ben David E; Ohnona FS; Schlesinger Y
Pediatr Infect Dis J; 2006 Oct; 25(10):898-901. PubMed ID: 17006284
[TBL] [Abstract][Full Text] [Related]
17. Infection and immunity for human parvovirus B19 in patients with febrile exanthema.
Pedranti MS; Barbero P; Wolff C; Ghietto LM; Zapata M; Adamo MP
Epidemiol Infect; 2012 Mar; 140(3):454-61. PubMed ID: 21676356
[TBL] [Abstract][Full Text] [Related]
18. Frequency and genotype of human parvovirus B19 among Iranian patients infected with HIV.
Azadmanesh K; Mohraz M; Kazemimanesh M; Aghakhani A; Foroughi M; Banifazl M; Eslamifar A; Ramezani A
J Med Virol; 2015 Jul; 87(7):1124-9. PubMed ID: 25771750
[TBL] [Abstract][Full Text] [Related]
19. Identification of past and recent parvovirus B19 infection in immunocompetent individuals by quantitative PCR and enzyme immunoassays: a dual-laboratory study.
Maple PA; Hedman L; Dhanilall P; Kantola K; Nurmi V; Söderlund-Venermo M; Brown KE; Hedman K
J Clin Microbiol; 2014 Mar; 52(3):947-56. PubMed ID: 24403307
[TBL] [Abstract][Full Text] [Related]
20. Baculovirus expression of parvovirus B19 (B19V) NS1: utility in confirming recent infection.
Ennis O; Corcoran A; Kavanagh K; Mahon BP; Doyle S
J Clin Virol; 2001 Aug; 22(1):55-60. PubMed ID: 11418353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
